NRIX
Price
$9.72
Change
-$0.19 (-1.92%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
757.61M
31 days until earnings call
NTRB
Price
$6.39
Change
+$0.01 (+0.16%)
Updated
Sep 8, 03:03 PM (EDT)
Capitalization
76.1M
23 days until earnings call
Interact to see
Advertisement

NRIX vs NTRB

Header iconNRIX vs NTRB Comparison
Open Charts NRIX vs NTRBBanner chart's image
Nurix Therapeutics
Price$9.72
Change-$0.19 (-1.92%)
Volume$19.22K
Capitalization757.61M
Nutriband
Price$6.39
Change+$0.01 (+0.16%)
Volume$100
Capitalization76.1M
NRIX vs NTRB Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. NTRB commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and NTRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (NRIX: $9.91 vs. NTRB: $6.38)
Brand notoriety: NRIX and NTRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 99% vs. NTRB: 9%
Market capitalization -- NRIX: $757.61M vs. NTRB: $76.1M
NRIX [@Biotechnology] is valued at $757.61M. NTRB’s [@Biotechnology] market capitalization is $76.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileNTRB’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • NTRB’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than NTRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 6 TA indicator(s) are bullish while NTRB’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 6 bullish, 3 bearish.
  • NTRB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than NTRB.

Price Growth

NRIX (@Biotechnology) experienced а +6.10% price change this week, while NTRB (@Biotechnology) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

NTRB is expected to report earnings on Oct 01, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($758M) has a higher market cap than NTRB($76.1M). NTRB YTD gains are higher at: 35.456 vs. NRIX (-47.399). NTRB has higher annual earnings (EBITDA): -9.68M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. NTRB (2.96M). NTRB has less debt than NRIX: NTRB (282K) vs NRIX (51.9M). NRIX has higher revenues than NTRB: NRIX (88.4M) vs NTRB (2.4M).
NRIXNTRBNRIX / NTRB
Capitalization758M76.1M996%
EBITDA-212.78M-9.68M2,198%
Gain YTD-47.39935.456-134%
P/E RatioN/AN/A-
Revenue88.4M2.4M3,686%
Total Cash486M2.96M16,397%
Total Debt51.9M282K18,404%
FUNDAMENTALS RATINGS
NTRB: Fundamental Ratings
NTRB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXNTRB
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEGYX23.570.17
+0.73%
Invesco International Small Company Y
CSSCX21.460.14
+0.66%
Columbia Small Cap Value Discv C
IWIRX62.290.30
+0.48%
Guinness Atkinson™ Global Inntrs Inv
GBCCX15.77-0.02
-0.13%
Gabelli Dividend Growth C
PRGSX69.95-0.12
-0.17%
T. Rowe Price Global Stock

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+8.66%
KYMR - NRIX
68%
Closely correlated
+3.10%
IDYA - NRIX
60%
Loosely correlated
+5.15%
DNLI - NRIX
58%
Loosely correlated
+4.33%
CRNX - NRIX
57%
Loosely correlated
+3.97%
BEAM - NRIX
55%
Loosely correlated
+12.62%
More

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and ABSI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and ABSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+2.41%
ABSI - NTRB
29%
Poorly correlated
+2.50%
STOK - NTRB
27%
Poorly correlated
+5.35%
NRIX - NTRB
27%
Poorly correlated
+8.66%
NTLA - NTRB
26%
Poorly correlated
+3.79%
KYMR - NTRB
26%
Poorly correlated
+3.10%
More